209 related articles for article (PubMed ID: 794749)
1. [Clinical experience with bromocriptine, a central dopaminergic stimulator].
Ludin HP; Kunz F; Lörincz P; Ringwald E
Nervenarzt; 1976 Nov; 47(11):651-5. PubMed ID: 794749
[No Abstract] [Full Text] [Related]
2. Comparison between lergotrile and bromocriptine in parkinsonism.
Teychenne PF; Pfeiffer RF; Bern SM; McInturff D; Calne DB
Ann Neurol; 1978 Apr; 3(4):319-24. PubMed ID: 666273
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of parkinsonian syndromes by bromocriptin].
Gautier JC; Durand JP
Nouv Presse Med; 1977 Jan; 6(3):171-4. PubMed ID: 319421
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic agonists in Parkinsonism.
Claveria LE; Teychenne PF; Calne DB; Petrie A; Bassendine MF
Adv Neurol; 1975; 9():383-92. PubMed ID: 1096576
[No Abstract] [Full Text] [Related]
5. An ergot derivative in the treatment of Parkinson's disease.
Calne DB; Shoulson I; Kartzinel R
Postgrad Med J; 1976; 52suppl 1():81-5. PubMed ID: 183198
[No Abstract] [Full Text] [Related]
6. Therapy of neurologic disorders in the elderly.
Mancall EL; Covington TR; Alonso RJ
Hosp Pract (Off Ed); 1984 Oct; 19(10):106E, 106I, 106L passim. PubMed ID: 6434551
[No Abstract] [Full Text] [Related]
7. [Treatment of Parkinson's disease with bromocriptine].
Castaigne P; Laplane D; Bousser MG; Bories F
Nouv Presse Med; 1976 Apr; 6(17):1482. PubMed ID: 1037400
[No Abstract] [Full Text] [Related]
8. Drug therapy: Bromocriptine.
Parkes D
N Engl J Med; 1979 Oct; 301(16):873-8. PubMed ID: 384250
[No Abstract] [Full Text] [Related]
9. Bromocriptine and lisuride in Parkinson disease.
Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Walker R; Hiesiger E
Ann Neurol; 1983 Jan; 13(1):44-7. PubMed ID: 6830164
[TBL] [Abstract][Full Text] [Related]
10. Lisuride treatment in Parkinson's disease: clinical and pharmacokinetic studies.
LeWitt PA; Burns RS; Calne DB
Adv Neurol; 1983; 37():131-40. PubMed ID: 6344586
[TBL] [Abstract][Full Text] [Related]
11. [Letter: Effect of bromocryptine on the fluctuations following dopa therapy. On-off phenomenon in parkinsonian patients].
Frattola L; Albizzati MG; Spano PF; Trabucchi M
Nouv Presse Med; 1976 Aug 28-Sep 4; 5(28):1761. PubMed ID: 958891
[No Abstract] [Full Text] [Related]
12. Comparison of the effects of bromocriptine and levodopa in Parkinson's disease.
Godwin-Austen RB; Smith NJ
J Neurol Neurosurg Psychiatry; 1977 May; 40(5):479-82. PubMed ID: 330825
[TBL] [Abstract][Full Text] [Related]
13. [Oral lisuride in Parkinson's disease].
Obeso JA; Luquin MR; Martínez Lage JM
Med Clin (Barc); 1985 Sep; 85(8):307-12. PubMed ID: 4068822
[No Abstract] [Full Text] [Related]
14. Psychiatric effects of bromocriptine and lergotrile in Parkinsonian patients.
Serby M; Angrist B; Lieberman A
Adv Biochem Psychopharmacol; 1980; 23():287-92. PubMed ID: 6104908
[No Abstract] [Full Text] [Related]
15. Bromocriptine in Parkinson disease.
Lieberman AN; Goldstein M
Pharmacol Rev; 1985 Jun; 37(2):217-27. PubMed ID: 3901046
[TBL] [Abstract][Full Text] [Related]
16. Studies with bromocriptine. Part 1. "On-off" phenomena.
Kartznel R; Calne DB
Neurology; 1976 Jun; 26(6 PT 1):508-10. PubMed ID: 945489
[TBL] [Abstract][Full Text] [Related]
17. Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism.
Kartzinel R; Shoulson I; Calne DB
Neurology; 1976 Jun; 26(6 PT 1):511-3. PubMed ID: 778655
[TBL] [Abstract][Full Text] [Related]
18. [The treatment of Parkinson disease using the combination bromocriptine and levodopa].
Dufresne JJ
Rev Med Suisse Romande; 1990 Jun; 110(6):559-64. PubMed ID: 2367793
[No Abstract] [Full Text] [Related]
19. Treatment of early morning akinesia with low-dose bromocriptine.
Lindvall B; Olsson JE
Adv Neurol; 1987; 45():543-5. PubMed ID: 3548264
[No Abstract] [Full Text] [Related]
20. [Considerations in the drug treatment of parkinsonism (author's transl)].
Hungerbühler JP; Regli F
Schweiz Rundsch Med Prax; 1978 Nov; 67(45):1648-57. PubMed ID: 30976
[No Abstract] [Full Text] [Related]
[Next] [New Search]